Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹948.40
Market cap: ₹418.6 Cr
Revenue (annual): ₹168.7 Cr
Net profit (annual): ₹34.74 Cr
P/E (TTM): 12.8×Sector 50.4×
Promoter holding: 46.62%-0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 2 Financial Results 2 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Aug 2026 20:00 IST BSE

Financial Results

Jenburkt Pharmaceuticals Q1 FY27 Results: Net Profit ₹5.9 Cr, Down 24.4% YoY

Jenburkt Pharmaceuticals Ltd reported revenue from operations of ₹35.5 Cr (+0.0% YoY) and net profit of ₹5.9 Cr (-24.4% YoY) for Q1 FY27.

Key figure: Net profit ₹5.9 Cr · -24.4% YoY

Open full results → Read the filing ↗

3 Aug 2026 15:13 IST BSE

Financial Results

Jenburkt Pharmaceuticals Q4 FY26 Results: Net Profit ₹34.7 Cr, Up 8.1% YoY

Jenburkt Pharmaceuticals Ltd reported revenue from operations of ₹168.7 Cr (+11.2% YoY) and net profit of ₹34.7 Cr (+8.1% YoY) for Q4 FY26.

Key figure: Net profit ₹34.7 Cr · +8.1% YoY

Open full results → Read the filing ↗